Glow Lifetech Corp. (GLWLF)
USD 0.04
(-10.06%)
USD 0.04
(-10.06%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 1.77 Million USD | 109.97% |
| 2022 | 843.04 Thousand USD | 225.07% |
| 2021 | 259.33 Thousand USD | 4.7% |
| 2020 | 247.7 Thousand USD | 78.4% |
| 2019 | 138.84 Thousand USD | 62.53% |
| 2018 | 85.42 Thousand USD | -84.18% |
| 2017 | 540 Thousand USD | 295.19% |
| 2016 | 136.64 Thousand USD | -70.17% |
| 2015 | 458.08 Thousand USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 1.88 Million USD | 8.69% |
| 2024 Q2 | 1.87 Million USD | 0.48% |
| 2023 Q1 | 960.36 Thousand USD | 13.92% |
| 2023 Q4 | 1.77 Million USD | 21.24% |
| 2023 Q3 | 1.46 Million USD | 13.37% |
| 2023 Q2 | 1.28 Million USD | 34.1% |
| 2023 FY | 1.77 Million USD | 109.97% |
| 2022 Q2 | 458.79 Thousand CAD | 43.48% |
| 2022 Q1 | 319.76 Thousand CAD | 23.3% |
| 2022 Q4 | 843.04 Thousand USD | 17.2% |
| 2022 FY | 843.04 Thousand USD | 225.07% |
| 2022 Q3 | 719.31 Thousand USD | 56.78% |
| 2021 Q1 | 172.38 Thousand CAD | -45.37% |
| 2021 FY | 259.33 Thousand USD | 4.7% |
| 2021 Q4 | 259.33 Thousand CAD | -48.33% |
| 2021 Q3 | 501.95 Thousand CAD | -9.3% |
| 2021 Q2 | 553.44 Thousand CAD | 221.05% |
| 2020 FY | 247.7 Thousand USD | 78.4% |
| 2020 Q4 | 315.57 Thousand CAD | -2.83% |
| 2020 Q3 | 324.74 Thousand CAD | 35.04% |
| 2020 Q2 | 240.49 Thousand CAD | 18.73% |
| 2020 Q1 | 202.55 Thousand CAD | 12.5% |
| 2019 FY | 138.84 Thousand USD | 62.53% |
| 2019 Q4 | 180.05 Thousand CAD | 0.0% |
| 2018 FY | 85.42 Thousand USD | -84.18% |
| 2017 FY | 540 Thousand USD | 295.19% |
| 2016 FY | 136.64 Thousand USD | -70.17% |
| 2015 FY | 458.08 Thousand USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | 53.3 Million USD | 96.679% |
| Nanobac Pharmaceuticals, Incorporated | 9.58 Million USD | 81.526% |
| SQZ Biotechnologies Company | 50.03 Million USD | 96.462% |
| Evofem Biosciences, Inc. | 72.47 Million USD | 97.557% |
| Santhera Pharmaceuticals Holding AG | 59.01 Million USD | 97.0% |
| Mesoblast Limited | 188.44 Million USD | 99.061% |
| Propanc Biopharma, Inc. | 3.85 Million USD | 54.039% |
| Genus plc | 485 Million USD | 99.635% |
| VioQuest Pharmaceuticals, Inc. | 5.84 Million USD | 69.703% |
| CNBX Pharmaceuticals Inc. | 2.51 Million USD | 29.653% |
| Marizyme, Inc. | 26.67 Million USD | 93.364% |
| ContraFect Corporation | 32.53 Million USD | 94.559% |
| Nymox Pharmaceutical Corporation | 3.8 Million USD | 53.417% |
| PsyBio Therapeutics Corp. | 1.98 Million USD | 10.657% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 3.82 Million USD | 53.753% |
| Intellipharmaceutics International Inc. | 12 Million USD | 85.259% |
| AXIM Biotechnologies, Inc. | 11.77 Million USD | 84.971% |
| MultiCell Technologies, Inc. | 1617.67 USD | -109326.459% |
| Accustem Sciences Inc. | 1.07 Million USD | -64.019% |
| RVL Pharmaceuticals plc | 77.41 Million USD | 97.713% |
| EV Biologics, Inc. | 2.11 Million USD | 16.307% |
| Q BioMed Inc. | 8.13 Million USD | 78.235% |
| Emmaus Life Sciences, Inc. | 82.93 Million USD | 97.866% |
| Neon Bloom, Inc. | 1.22 Million USD | -44.36% |
| Mosaic ImmunoEngineering Inc. | 5.14 Million USD | 65.601% |
| Biomind Labs Inc. | 1.49 Million USD | -18.12% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Pharming Group N.V. | 244.07 Million USD | 99.275% |
| Oncotelic Therapeutics, Inc. | 18.4 Million USD | 90.381% |
| Skye Bioscience, Inc. | 14.07 Million USD | 87.421% |
| Therapeutic Solutions International, Inc. | 2.01 Million USD | 11.938% |
| THC Farmaceuticals, Inc. | 142.09 Thousand USD | -1145.757% |
| Arch Therapeutics, Inc. | 9.46 Million USD | 81.3% |
| IMV Inc. | 37.93 Million USD | 95.333% |
| Acro Biomedical Co., Ltd. | 201.11 Thousand USD | -780.168% |
| Curative Biotechnology, Inc. | 5.74 Million USD | 69.192% |
| GB Sciences, Inc. | 5.41 Million USD | 67.326% |
| Alpha Cognition Inc. | 7.16 Million USD | 75.294% |
| HST Global, Inc. | 593.59 Thousand USD | -198.211% |
| CSL Limited | 18.62 Billion USD | 99.99% |
| Halberd Corporation | 728.71 Thousand USD | -142.914% |
| Enzolytics Inc. | 365.26 Million USD | 99.515% |
| Resverlogix Corp. | 67.39 Million USD | 97.373% |
| Affymax, Inc. | 8.87 Million USD | 80.046% |
| SYBLEU INC | 681.41 Thousand USD | -159.778% |
| Nuo Therapeutics, Inc. | 838.73 Thousand USD | -111.052% |
| argenx SE | 444.95 Million USD | 99.602% |
| MetaStat, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | 74.92 Million USD | 97.637% |
| Enzon Pharmaceuticals, Inc. | 1.71 Million USD | -3.276% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| RespireRx Pharmaceuticals Inc. | 11.9 Million USD | 85.129% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | 3.66 Million USD | 51.703% |
| AVAX Technologies, Inc. | 3.99 Million USD | 55.677% |
| Zenith Capital Corp. | 27.56 Thousand USD | -6320.831% |
| Genscript Biotech Corporation | 1.32 Billion USD | 99.866% |
| Ember Therapeutics, Inc. | 238.65 Thousand USD | -641.726% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 3.73 Million USD | 52.597% |
| WPD Pharmaceuticals Inc. | 680.83 Thousand USD | -159.999% |
| American Oriental Bioengineering, Inc. | 118.72 Million USD | 98.509% |
| Provectus Biopharmaceuticals, Inc. | 9.04 Million USD | 80.423% |
| Adynxx, Inc. | - USD | -Infinity% |
| Helix BioMedix, Inc. | 66.92 Thousand USD | -2544.831% |
| GlobeStar Therapeutics Corporation | 1.43 Million USD | -23.454% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 50.26 Million USD | 96.478% |
| Cotinga Pharmaceuticals Inc. | 2.71 Million USD | 34.72% |
| BioStem Technologies, Inc. | 15.9 Million USD | 88.87% |
| ONE Bio Corp. | 27.49 Million USD | 93.562% |
| Reve Technologies, Inc. | 464.69 Thousand USD | -280.926% |
| Burzynski Research Institute, Inc. | 27.43 Thousand USD | -6352.663% |
| Wesana Health Holdings Inc. | 1.25 Million USD | -40.579% |
| Agentix Corp. | 2.51 Million USD | 29.491% |
| LadRx Corporation | 2.2 Million USD | 19.558% |
| Cell Source, Inc. | 15.8 Million USD | 88.801% |
| ProtoKinetix, Incorporated | 44.69 Thousand USD | -3860.442% |
| Regen BioPharma, Inc. | 5.45 Million USD | 67.565% |
| Regen BioPharma, Inc. | 5.45 Million USD | 67.565% |
| NovAccess Global Inc. | 7.86 Million USD | 77.481% |
| Endonovo Therapeutics, Inc. | 24.74 Million USD | 92.847% |
| Itoco Inc. | 1.65 Million USD | -7.078% |
| Rasna Therapeutics, Inc. | 2.05 Million USD | 13.717% |
| Pathfinder Cell Therapy, Inc. | 6.04 Million USD | 70.736% |
| Kadimastem Ltd | 3.5 Million USD | 49.494% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Institute of Biomedical Research Corp. | 421.56 Thousand USD | -319.899% |
| CytoDyn Inc. | 127.89 Million USD | 98.616% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | 41.79 Thousand USD | -4134.931% |
| Mobile Lads Corp. | 1.31 Million USD | -34.767% |
| NanoSphere Health Sciences Inc. | 1.56 Million USD | -13.01% |
| Qrons Inc. | 1.48 Million USD | -18.905% |
| Alseres Pharmaceuticals, Inc. | 11.04 Million USD | 83.974% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | 808.79 Thousand USD | -118.864% |
| Rebus Holdings, Inc. | 5.24 Million USD | 66.231% |
| ImmunoCellular Therapeutics, Ltd. | 6.1 Million USD | 70.99% |
| International Stem Cell Corporation | 5.27 Million USD | 66.455% |
| Bioxytran, Inc. | 3.24 Million USD | 45.525% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 625.8 Thousand USD | -182.859% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 4.61 Million USD | 61.661% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 40.99 Million USD | 95.682% |
| Adhera Therapeutics, Inc. | 22.26 Million USD | 92.05% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 2.02 Million USD | 12.601% |
| Innovation Pharmaceuticals Inc. | 5.47 Million USD | 67.686% |
| Neutra Corp. | 973.52 Thousand USD | -81.829% |
| Windtree Therapeutics, Inc. | 29.01 Million USD | 93.899% |
| PureTech Health plc | 125.58 Million USD | 98.59% |
| Coeptis Therapeutics, Inc. | 3.75 Million USD | 52.885% |
| IXICO plc | 1.9 Million USD | 6.848% |
| IntelGenx Technologies Corp. | 20.52 Million USD | 91.377% |
| Gelesis Holdings, Inc. | 103.32 Million USD | 98.287% |
| CSL Limited | 18.62 Billion USD | 99.99% |
| Cellectis S.A. | 249.36 Million USD | 99.29% |